{
    "Trade/Device Name(s)": [
        "BD ProbeTec Herpes Simplex Viruses (HSV 1 & 2) Qx Amplified DNA Assays",
        "BD ProbeTec Herpes Simplex Viruses (HSV 1 & 2) Q Amplified DNA Assays",
        "BD ProbeTec Herpes Simplex Viruses (HSV1 & 2) Qr Amplified DNA Assays"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K103798",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "0QO"
    ],
    "Summary Letter Date": "December 22, 2010",
    "Summary Letter Received Date": "December 27, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Nucleic Acid Amplification Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes Simplex virus type 1 DNA",
        "Herpes Simplex virus type 2 DNA"
    ],
    "Specimen Type(s)": [
        "External anogenital lesion swab"
    ],
    "Specimen Container(s)": [
        "Universal Viral Transport (UVT)",
        "Qx Swab Diluent Tube",
        "Cryovial"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative DNA detection",
        "Target-specific fluorescent probe analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Herpes Simplex Viruses (HSV 1 & 2) Qx Amplified DNA Assays for qualitative detection and differentiation of HSV1 and HSV2 DNA in anogenital lesion swabs using SDA on BD Viper System.",
    "Indications for Use Summary": "Qualitative detection and differentiation of HSV1 and HSV2 DNA in clinician-collected external anogenital lesion specimens from symptomatic individuals, to aid in diagnosis of anogenital HSV1 and HSV2 infections.",
    "fda_folder": "Microbiology"
}